Library — CHDR

Search

Filter

Key publication (484)
Poster (21)
PhD Thesis (16)
Brochure (19)
Factsheet (4)
Annual report (6)

Morphological characteristics and HPV genotype predict the treatment response in cutaneous warts.

Hogendoorn GK, Bruggink SC, de Koning MNC, Eekhof JAH, Hermans KE, Rissmann R, Burggraaf J, Wolterbeek R, Quint KD, Kouwenhoven STP, Bavinck JNB

The British journal of dermatology, 2017 Jul

View publication
Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial.

Heuberger JAAC, Rotmans JI, Gal P, Stuurman FE, van 't Westende J, Post TE, Daniels JMA, Moerland M, van Veldhoven PLJ, de Kam ML, Ram H, de Hon O, Posthuma JJ, Burggraaf J, Cohen AF

The Lancet. Haematology, 2017 Jun

View publication
Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.

van Meir H, Nout RA, Welters MJ, Loof NM, de Kam ML, van Ham JJ, Samuels S, Kenter GG, Cohen AF, Melief CJ, Burggraaf J, van Poelgeest MI, van der Burg SH

Oncoimmunology, 2017 May; 6(2):e1267095

View publication
Pharmacodynamic response profiles of anxiolytic and sedative drugs.

Chen X, Broeyer F, de Kam M, Baas J, Cohen A, van Gerven J

British journal of clinical pharmacology, 2017 Apr; 83(5):1028-1038

View publication
Pharmacokinetics and pharmacodynamics of oral mecamylamine - development of a nicotinic acetylcholine receptor antagonist cognitive challenge test using modelling and simulation.

Alvarez-Jimenez R, Baakman AC, Stevens J, Goulooze SC, Hart EP, Rissmann R, van Gerven JM, Groeneveld GJ

Journal of psychopharmacology (Oxford, England), 2017 Jan; 31(2):192-203

View publication
Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS.

Monnet E, Lapeyre G, Poelgeest EV, Jacqmin P, Graaf K, Reijers J, Moerland M, Burggraaf J, Min C

Clinical pharmacology and therapeutics, 2017 Jan; 101(2):200-208

View publication
Effects of a single, oral 60 mg caffeine dose on attention in healthy adult subjects.

Wilhelmus MM, Hay JL, Zuiker RG, Okkerse P, Perdrieu C, Sauser J, Beaumont M, Schmitt J, van Gerven JM, Silber BY

Journal of psychopharmacology (Oxford, England), 2017 Jan; 31(2):222-232

View publication
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.

Balak DM, van Doorn MB, Arbeit RD, Rijneveld R, Klaassen E, Sullivan T, Brevard J, Thio HB, Prens EP, Burggraaf J, Rissmann R

Clinical immunology (Orlando, Fla.), 2016 Dec

View publication
Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation.

Klaassens BL, Rombouts SA, Winkler AM, van Gorsel HC, van der Grond J, van Gerven JM

Human brain mapping, 2016 Dec; 38(1):308-325

View publication

«
1
2
3
4
5
6
7
8
...
53
54
»